Cargando…
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
Respiratory syncytial virus (RSV) is a leading cause of respiratory infections worldwide and disease management measures are hampered by the lack of a safe and effective vaccine against the infection. We constructed a novel recombinant RSV vaccine candidate based on a deletion mutant vaccinia virus...
Autores principales: | Russell, Marsha S., Thulasi Raman, Sathya N., Gravel, Caroline, Zhang, Wanyue, Pfeifle, Annabelle, Chen, Wangxue, Van Domselaar, Gary, Safronetz, David, Johnston, Michael, Sauve, Simon, Wang, Lisheng, Rosu-Myles, Michael, Cao, Jingxin, Li, Xuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484905/ https://www.ncbi.nlm.nih.gov/pubmed/34603336 http://dx.doi.org/10.3389/fimmu.2021.747866 |
Ejemplares similares
-
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
por: Raman, Sathya N. Thulasi, et al.
Publicado: (2023) -
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
por: Gravel, Caroline, et al.
Publicado: (2021) -
DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice
por: Pfeifle, Annabelle, et al.
Publicado: (2023) -
Dysregulation of Ephrin receptor and PPAR signaling pathways in neural progenitor cells infected by Zika virus
por: Thulasi Raman, Sathya N., et al.
Publicado: (2020) -
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model
por: Tamming, Levi A., et al.
Publicado: (2022)